Anifrolumab-fnia -(SAPNELO)- (July 2021)- To treat moderate to-severe- systemic lupus erythematousus along with standard therapy

Drug Name:
Anifrolumab-fnia -(SAPNELO)- (July 2021)- To treat moderate to-severe- systemic lupus erythematousus along with standard therapy

List Of Brands:

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation